These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 26414077)
21. Preparation of virus-like particle mimetic nanovesicles displaying the S protein of Middle East respiratory syndrome coronavirus using insect cells. Kato T; Takami Y; Kumar Deo V; Park EY J Biotechnol; 2019 Dec; 306():177-184. PubMed ID: 31614169 [TBL] [Abstract][Full Text] [Related]
22. Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review. Choi J; Kim MG; Oh YK; Kim YB Expert Opin Ther Pat; 2017 Jun; 27(6):721-731. PubMed ID: 28121202 [TBL] [Abstract][Full Text] [Related]
23. Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice. Kato H; Takayama-Ito M; Iizuka-Shiota I; Fukushi S; Posadas-Herrera G; Horiya M; Satoh M; Yoshikawa T; Yamada S; Harada S; Fujii H; Shibamura M; Inagaki T; Morimoto K; Saijo M; Lim CK PLoS One; 2019; 14(10):e0223684. PubMed ID: 31589656 [TBL] [Abstract][Full Text] [Related]
24. MERS-CoV spike protein: Targets for vaccines and therapeutics. Wang Q; Wong G; Lu G; Yan J; Gao GF Antiviral Res; 2016 Sep; 133():165-77. PubMed ID: 27468951 [TBL] [Abstract][Full Text] [Related]
25. Current advancements and potential strategies in the development of MERS-CoV vaccines. Zhang N; Jiang S; Du L Expert Rev Vaccines; 2014 Jun; 13(6):761-74. PubMed ID: 24766432 [TBL] [Abstract][Full Text] [Related]
26. Vaccines against Middle East respiratory syndrome coronavirus for humans and camels. Alharbi NK Rev Med Virol; 2017 Mar; 27(2):. PubMed ID: 27786402 [TBL] [Abstract][Full Text] [Related]
31. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus. Kim MH; Kim HJ; Chang J PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652 [TBL] [Abstract][Full Text] [Related]
32. Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain. Zhou Y; Yang Y; Huang J; Jiang S; Du L Viruses; 2019 Jan; 11(1):. PubMed ID: 30646569 [TBL] [Abstract][Full Text] [Related]
33. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases. Shi J; Zhang J; Li S; Sun J; Teng Y; Wu M; Li J; Li Y; Hu N; Wang H; Hu Y PLoS One; 2015; 10(12):e0144475. PubMed ID: 26641892 [TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein. Al-Amri SS; Abbas AT; Siddiq LA; Alghamdi A; Sanki MA; Al-Muhanna MK; Alhabbab RY; Azhar EI; Li X; Hashem AM Sci Rep; 2017 Mar; 7():44875. PubMed ID: 28332568 [TBL] [Abstract][Full Text] [Related]
35. Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches. Okba NM; Raj VS; Haagmans BL Curr Opin Virol; 2017 Apr; 23():49-58. PubMed ID: 28412285 [TBL] [Abstract][Full Text] [Related]
36. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV. Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421 [TBL] [Abstract][Full Text] [Related]
37. [Bioinformatics-based Design of Peptide Vaccine Candidates Targeting Spike Protein of MERS-CoV and Immunity analysis in Mice]. Lan J; Lu S; Deng Y; Wen B; Chen H; Wang W; Tan W Bing Du Xue Bao; 2016 Jan; 32(1):77-81. PubMed ID: 27295887 [TBL] [Abstract][Full Text] [Related]
38. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Deng Y; Lan J; Bao L; Huang B; Ye F; Chen Y; Yao Y; Wang W; Qin C; Tan W Emerg Microbes Infect; 2018 Apr; 7(1):60. PubMed ID: 29618723 [TBL] [Abstract][Full Text] [Related]
39. Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Agrawal AS; Tao X; Algaissi A; Garron T; Narayanan K; Peng BH; Couch RB; Tseng CT Hum Vaccin Immunother; 2016 Sep; 12(9):2351-6. PubMed ID: 27269431 [TBL] [Abstract][Full Text] [Related]
40. Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge. Lan J; Yao Y; Deng Y; Chen H; Lu G; Wang W; Bao L; Deng W; Wei Q; Gao GF; Qin C; Tan W EBioMedicine; 2015 Oct; 2(10):1438-46. PubMed ID: 26629538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]